The DOI matches its Crossref record; 92 of the 94 references it cites were found in a registry or an index; 36 of the 105 sources its claims cite were checked for support.
Illness Anxiety Disorder: A Review of the Current Research and Future Directions
Open accessAbstract
Purpose of Review: We review recent evidence on Illness Anxiety Disorder (IAD), including risk factors and precipitants, diagnostic classification, clinical characteristics of the disorder, and assessment and treatment in both children and adults. Recent Findings: IAD places a substantial burden on both individuals and society. Despite its impact, understanding of the disorder is lacking and debates remain about whether IAD should be classified as an anxiety disorder and whether it is distinct from Somatic Symptom Disorder. Cognitive behavioural therapy (CBT) is an effective treatment for IAD and there are multiple validated measures of health anxiety available. However, research on health anxiety in children and youth is limited. Summary: IAD is chronic, and debilitating, but when identified, it can be effectively treated with CBT. Research using DSM-5 IAD criteria is lacking, and more research is needed to better understand the disorder, particularly in children and youth. © The Author(s) 2024.
Overview
CoChat Summary
## TL;DR
Illness Anxiety Disorder (IAD) is described as a chronic, debilitating condition, with current evidence supporting CBT as an effective treatment and multiple validated assessment measures available. However, the review emphasizes that DSM-5 IAD research remains limited, especially for children and youth, risk factors, and the disorder’s classification relative to Somatic Symptom Disorder.
## Key findings
- Health anxiety/IAD is reported to have a substantial burden: prevalence in the general adult population is estimated at 2.1–13.1%, and in medical settings at 7%–19.9%.
- The disorder is described as chronic, episodic, and lasting for years if untreated, with health-anxious individuals reporting worse self-rated health, more daily interference, more personal distress, increased early mortality risk, and higher health care use.
- CBT is presented as an effective intervention, with meta-analytic evidence showing a moderate to large pooled effect size (Hedge’s g = 0.81, 95% CI [0.37, 1.26]) versus non-CBT controls, and benefits largely maintained over 12–18 months.
- In the only subtype prevalence study the review cites, 25% met criteria for the care-seeking subtype, 14% for care-avoidant, and 61% fluctuated between seeking and avoiding care.
## Methods
- Narrative review of recent literature on IAD/health anxiety, covering risk factors, classification, clinical features, assessment, and treatment across children and adults.
- Synthesizes findings from prior studies, including meta-analyses, systematic reviews, randomized controlled trials, and psychometric studies of assessment instruments.
- The review draws on literature using both DSM-5 IAD criteria and broader dimensional health anxiety measures.
## Limitations
- The paper states that research using DSM-5 IAD criteria is lacking, and that the optimal cut-off scores for common health-anxiety measures in IAD samples are unknown.
- It states that research on children and youth is limited, with no treatment studies of CBT for IAD/health anxiety in that age group and no studies of third-wave therapies or pharmacological approaches in young people.
- Evident from the text: much of the evidence base the review summarizes comes from hypochondriasis or dimensional health anxiety studies rather than studies of DSM-5 IAD specifically.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
25 Valid · 10 Not valid · 28 Not checked · 13 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Additionally, research has shown that both IAD and SSD respond similarly to psychological treatment [26].”
§ Illness Anxiety Disorder: A Review of the Current Research and Future Directions > Issues with Diagnosis and Classification > Diagnostic Criteria According to the DSM-5, IAD is only diagnosed when a person experiences either no or mild somatic symptoms. If they experience health anxiety with moderate to severe somatic symptoms, they may be diagnosed with Somatic Symptom Disorder (SSD) instead [1]. For an IAD diagnosis, the individual will experience excessive worry about either having or developing a serious medical illness, which persists for six months or more. The individual will be highly vigilant about their personal health status, resulting in various maladaptive coping behaviours (i.e., checking their bodies for signs of illness, excessively searching the internet for health-related information, and making frequent visits to medical settings). Individuals with an SSD diagnosis will experience excessive and persistent thoughts related to the seriousness of their moderate-to severe somatic symptoms, and/or high levels of anxiety about their health or symptoms and dedicate significant time to researching and understanding their symptoms in depth. Their somatic symptoms must also last longer than 6 months but can change across their course. IAD and SSD were put forward to replace DSM-IV Hypochondriasis due to its limited clinical validity, and research suggests that IAD and SSD are more reliable than Hypochondriasis [12]. However, having two separate diagnoses is not clinically useful, as research has found there are few differences in how individuals with health anxiety experience the disorders [12, 23••, 24, 25]. Specifically, the differences that have been reported relate to symptom severity, whereby IAD characterizes individuals with a milder form of health anxiety and SSD represents individuals with a more severe form of health anxiety. Additionally, research has shown that both IAD and SSD respond similarly to psychological treatment [26]. Furthermore, recent research done by our team [25] showed that there were no differences on demographic characteristics, clinical characteristics (i.e., depression and generalized anxiety severity, quality of life related to mental health), the nature and course of health anxiety, or mental health comorbidity, between people who met IAD criteria with no/mild somatic symptoms versus those with moderate-to-severe somatic symptoms. These findings suggest that the distinction in somatic symptom severity between these disorders might be arbitrary [25, 27]. Further research is needed to understand whether restricting IAD to only those with minimal somatic symptoms is clinically useful. The DSM-5 categorizes IAD into two subtypes: ‘care-seeking’ for individuals that frequently seek medical care, and ‘care-avoidant’ for individuals that frequently avoid medical care. Although researchers have proposed that individuals seek care as a form of reassurance and avoid care out of an overwhelming fear of having a serious disease [28], evidence about these behaviours remains scarce. To date, our team conducted the only study investigating the prevalence of IAD subtypes and found that 25% met criteria for the ‘care-seeking’ subtype, 14% met criteria for the ‘care-avoidant’ subtype, and interestingly, 61% reported fluctuating between seeking and avoiding care. This suggests that there may be a third subtype of IAD which needs further study [12].
What the sources say
- Supportedcites [26] Newby JM, Smith J, Uppal S, Mason E, Mahoney AEJ, Andrews G. Internet-based cognitive behavioral therapy versus psychoeducation control for illness anxiety disorder and somatic symptom disorder: A randomized controlled trial. J Consult Clin Psychol. 2018;86(1):89–98. https://doi.org/10.1037/ccp0000248. source
The Discussion states that participants with IAD and SSD benefited equally from internet-based CBT after accounting for higher baseline health anxiety in the SSD group. The Results likewise report no significant difference in post-treatment health-anxiety scores after that adjustment. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Similarly, substantial comorbidity was found between DSM-5 IAD and other anxiety disorders, particularly Generalized Anxiety Disorder and Panic Disorder [12].”
§ Illness Anxiety Disorder: A Review of the Current Research and Future Directions > Issues with Diagnosis and Classification > Classification
What the sources say
- Supportedcites [12] Newby JM, Hobbs MJ, Mahoney AEJ, Wong S, Andrews G. DSM-5 illness anxiety disorder and somatic symptom disorder: comorbidity, correlates, and overlap with DSM-IV hypochondriasis. J Psychosom Res. 2017;101:31–7. https://doi.org/10.1016/j.jpsychores.2017.07.010. source
The “Validity of DSM-5 IAD and SSD” section explicitly reports substantial comorbidity between IAD and anxiety disorders and identifies GAD and panic disorder as the most common anxiety disorders. This directly supports the citing sentence. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Research using the DSM-IV Hypochondriasis criteria has shown higher levels of comorbidity with anxiety disorders than comorbid depressive or somatoform disorders [33].”
§ Illness Anxiety Disorder: A Review of the Current Research and Future Directions > Issues with Diagnosis and Classification > Classification
What the sources say
- Supportedcites [33] Scarella TM, Laferton JA, Ahern DK, Fallon BA, Barsky A. The relationship of hypochondriasis to anxiety, depressive, and somatoform disorders. Psychosomatics. 2016;57(2):200–7. https://doi.org/10.1016/j.psym.2015.10.006. source
The Results section reports that anxiety disorders as a group were more common than depressive disorders as a group in patients with hypochondriasis; only four patients had a somatoform disorder as their sole comorbidity. The Conclusion identifies the condition studied as DSM-IV hypochondriasis. The comparison is within this study population, not a claim about all people with health anxiety. (LLM, conf=0.92)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These findings suggest that the distinction in somatic symptom severity between these disorders might be arbitrary [25, 27].”
§ Illness Anxiety Disorder: A Review of the Current Research and Future Directions > Issues with Diagnosis and Classification > Diagnostic Criteria According to the DSM-5, IAD is only diagnosed when a person experiences either no or mild somatic symptoms. If they experience health anxiety with moderate to severe somatic symptoms, they may be diagnosed with Somatic Symptom Disorder (SSD) instead [1]. For an IAD diagnosis, the individual will experience excessive worry about either having or developing a serious medical illness, which persists for six months or more. The individual will be highly vigilant about their personal health status, resulting in various maladaptive coping behaviours (i.e., checking their bodies for signs of illness, excessively searching the internet for health-related information, and making frequent visits to medical settings). Individuals with an SSD diagnosis will experience excessive and persistent thoughts related to the seriousness of their moderate-to severe somatic symptoms, and/or high levels of anxiety about their health or symptoms and dedicate significant time to researching and understanding their symptoms in depth. Their somatic symptoms must also last longer than 6 months but can change across their course. IAD and SSD were put forward to replace DSM-IV Hypochondriasis due to its limited clinical validity, and research suggests that IAD and SSD are more reliable than Hypochondriasis [12]. However, having two separate diagnoses is not clinically useful, as research has found there are few differences in how individuals with health anxiety experience the disorders [12, 23••, 24, 25]. Specifically, the differences that have been reported relate to symptom severity, whereby IAD characterizes individuals with a milder form of health anxiety and SSD represents individuals with a more severe form of health anxiety. Additionally, research has shown that both IAD and SSD respond similarly to psychological treatment [26]. Furthermore, recent research done by our team [25] showed that there were no differences on demographic characteristics, clinical characteristics (i.e., depression and generalized anxiety severity, quality of life related to mental health), the nature and course of health anxiety, or mental health comorbidity, between people who met IAD criteria with no/mild somatic symptoms versus those with moderate-to-severe somatic symptoms. These findings suggest that the distinction in somatic symptom severity between these disorders might be arbitrary [25, 27]. Further research is needed to understand whether restricting IAD to only those with minimal somatic symptoms is clinically useful. The DSM-5 categorizes IAD into two subtypes: ‘care-seeking’ for individuals that frequently seek medical care, and ‘care-avoidant’ for individuals that frequently avoid medical care. Although researchers have proposed that individuals seek care as a form of reassurance and avoid care out of an overwhelming fear of having a serious disease [28], evidence about these behaviours remains scarce. To date, our team conducted the only study investigating the prevalence of IAD subtypes and found that 25% met criteria for the ‘care-seeking’ subtype, 14% met criteria for the ‘care-avoidant’ subtype, and interestingly, 61% reported fluctuating between seeking and avoiding care. This suggests that there may be a third subtype of IAD which needs further study [12].
What the sources say
- Not matchedcites [25] Kikas K, Werner-Seidler A, Upton E, Corkish B, Newby J. Illness anxiety disorder and somatic symptom disorder in people who worry about health: Distinct diagnoses or one and the same?. Unpublished.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Supportedcites [27] Rief W, Martin A. How to use the new DSM-5 somatic symptom disorder diagnosis in research and practice: a critical evaluation and a proposal for modifications. Annu Rev Clin Psychol. 2014;10:339–67. https://doi.org/10.1146/annurev-clinpsy-032813-153745. source
In “The specifiers of somatic symptom disorder,” the paper says illness anxiety disorder was introduced for patients with serious illness anxiety who lack enough somatic symptoms to meet SSD criteria. In “Shortcomings of the New SSD Diagnosis in DSM-5,” it explicitly criticizes splitting hypochondriasis into two diagnoses. Together, these passages support the hedged claim that the symptom-based distinction might be arbitrary; page numbers were not available in our copy. (LLM, conf=0.86)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Overutilisation of health services is also considered a core maladaptive coping behaviour in health anxiety [11, 59].”
§ Illness Anxiety Disorder: A Review of the Current Research and Future Directions > Cognitive and Behavioural Aspects of Health Anxiety > Behavioural Components
What the sources say
- Partly supportedcites [11] Fink P, Ørnbøl E, Christensen KS. The outcome of health anxiety in primary care. A two-year follow-up study on health care costs and self-rated health. PLoS One. 2010;5(3):e9873. https://doi.org/10.1371/journal.pone.0009873. sourceExperimental — accuracy not yet measured
The Results (Health care utilization; page unavailable) report that patients with severe health anxiety used 41–78% more health care services than patients with a well-defined medical condition. The Discussion links illness worry to help-seeking and describes reassurance as only partial, but it does not establish overutilisation as a core maladaptive coping behaviour; it also reports lower use among patients with mild health anxiety. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [59] Horenstein A, Heimberg RG. Anxiety disorders and healthcare utilization: a systematic review. Clin Psychol Rev. 2020;81:101894. https://doi.org/10.1016/j.cpr.2020.101894. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
31 more claims · 5 with their cited sources checked
Create a free account to see all 76 claims and every source verdict.
- It may state two separate claims as one. 28
- Probably not a substantial claim. 16
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
SALKOVSKIS, P. M., RIMES, K. A., WARWICK, H. M. C., & CLARK, D. M. (2002) · Psychological Medicine · doi:10.1017/s0033291702005822 · Cited by 1,351 · cited 3×
“A shortened version of the Health Anxiety Inventory [66] and Whitley Index 6 [68] have been developed and widely used in clinical settings due to their practicality and brief nature [69, 70].”
BackgroundMethodInto the unknown: A review and synthesis of contemporary models involving uncertainty
Carleton, R. N. (2016) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2016.02.007 · Cited by 1,104 · cited 1×
“…anxiety include higher levels of anxiety sensitivity, the fear of arousal-related bodily sensations [50, 51], health-related rumination [52], and health-related intolerance of uncertainty which is essentially a reduced capacity to endure the perception of missing important information [53–55].”
BackgroundPilowsky, I. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.494.89 · Cited by 865 · cited 1×
“The three most widely used assessment measures are the Whitley Index [64], Illness Attitude Scale [65], and the Health Anxiety Inventory [66].”
MethodAnxiety sensitivity and the anxiety disorders: A meta-analytic review and synthesis.
Olatunji, B. O., & Wolitzky-Taylor, K. B. (2009) · Psychological Bulletin · doi:10.1037/a0017428 · Cited by 609 · cited 1×
“…cognitive constructs related to health anxiety include higher levels of anxiety sensitivity, the fear of arousal-related bodily sensations [50, 51], health-related rumination [52], and health-related intolerance of uncertainty which is essentially a reduced capacity to endure the perception…”
BackgroundFrequency, comorbidity, and psychosocial impairment of anxiety disorders in German adolescents
Essau, C. A., soc, R., Conradt, J., Petermann, F., & Phil (2000) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(99)00039-0 · Cited by 504 · cited 1×
“…research examining the prevalence of health anxiety using diagnostic criteria suggests that very few children meet full diagnostic criteria [18, 91, 92], leading researchers to argue that this could be due to a lack of appropriate descriptions of how severe health anxiety presents in children and…”
BackgroundSalkovskis, P. M., & Warwick, H. M. C. (1986) · Behaviour Research and Therapy · doi:10.1016/0005-7967(86)90041-0 · Cited by 475 · cited 2×
“Several life experiences have been proposed as pre-cipitants of health anxiety, such as experiencing major life stress, a serious threat to one’s health, witnessing a loved one’s illness, and being exposed to health-threatening information [34, 45].”
BackgroundAcute mental health responses during the COVID-19 pandemic in Australia
Newby, J. M., O’Moore, K., Tang, S., Christensen, H., & Faasse, K. (2020) · PLOS ONE · doi:10.1371/journal.pone.0236562 · Cited by 471 · cited 1×
“This increase has been further exacerbated by the COVID-19 pandemic, where health anxiety and fears of COVID-19 were common [10].”
BackgroundSelf-citationSomatization Symptoms and Hypochondriacal Features in the General Population
Rief, W., Hessel, A., & Braehler, E. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00012 · Cited by 339 · cited 1×
“Unlike depression and anxiety disorders, which tend to show higher rates in females, health anxiety affects men and women equally [13–15].”
BackgroundHealth Anxiety: Current Perspectives and Future Directions
Asmundson, G. J. G., Abramowitz, J. S., Richter, A. A., & Whedon, M. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0123-9 · Cited by 309 · cited 1×
“These typically comprise of reassurance-seeking from external sources (e.g., loved ones or doctors), excessive body checking behaviours (e.g., repeatedly taking blood pressure) and/or avoidance of disease-related cues (e.g., hospitals) [57].”
Background
Research works printed but not linked: 2
- Brown TA, Barlow DH. Anxiety and related disorders interview schedule for DSM-5 (ADIS-5)-adult and lifetime version: clinician manual. New York (US): Oxford University Press; 2014.
- First MB. Structured clinical interview for the DSM (SCID). In: Cautin RL, Lilienfeld SO, editors. Encycl Clin Psychol. Hoboken (NJ): Wiley; 2015. p. 1–6.
Cited by
Çol, B. K., Başaran, A. G., & Köse, B. G. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s513017 · Cited by 19
Liu, C., Mou, L., Zhang, Y., Zhang, M., Yang, P., Ma, S., Zhang, M., Huang, J., Xiao, X., & Liu, J. (2025) · Seizure · doi:10.1016/j.seizure.2025.01.004 · Cited by 5
Beames, J. R., Dabash, O., Spoelma, M. J., Shvetcov, A., Zheng, W. Y., Slade, A., Han, J., Hoon, L., Kupper, J. F., Parker, R., et al. (2025) · JMIR Formative Research · doi:10.2196/71377 · Cited by 2
Self-citationDutta, R. (2025) · International Journal of Cognitive Behavioral Therapy · doi:10.1007/s41811-025-00261-4 · Cited by 2
“A recent review study by Kikas et al. (2024) found that CBT is a highly efficacious and cost-effective treatment for health anxiety, with a moderate to large pooled effect size.”
InfluentialKim, S. H., Kim, G. L., Lee, J. G., Lee, Y. H., Tak, Y. J., Lee, S. H., Ra, Y. J., Lee, S. Y., Park, E. J., Cho, Y. H., et al. (2025) · Korean Journal of Family Medicine · doi:10.4082/kjfm.24.0219 · Cited by 2
“Anxiety disorders encompass a range of conditions; GAD is specifically characterized by persistent, un - controllable worry and anxiety lasting for more than 6 months [5].”
Metadata
- Authors
- Kikas, K., Werner-Seidler, A., Upton, E., & Newby, J.
- Affiliations
- Black Dog Institute (AU)
- Corresponding author
- Newby, Jill
- Venue
- Current Psychiatry Reports
- Published
- 2024-05-15
- Volume
- 26
- Issue
- 7
- Pages
- 331-339
- ISSN
- 1523-3812 (ISSN-L)
- 1535-1645
- PMC
- PMC11211185
- OpenAlex
- W4396914301
- Cited by
- 51
- References
- 94
- Citations by year
- 2026: 24 · 2025: 22 · 2024: 5
- FWCI
- 12.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Current Psychiatry Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- University of New South Wales
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Keywords
- health anxiety, somatic symptom disorder, cognitive behavioral therapy, risk factors, diagnostic classification, DSM-5 diagnostic criteria, children and young people, treatment outcomes
- MeSH terms
- Anxiety Disorders, Child, Humans, Cognitive Behavioral Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Illness Anxiety Disorder: A Review of the Current Research and Future Directions. https://app.cochat.ai/papers/10.1007/s11920-024-01507-2
- The paper
- Kikas, K., Werner-Seidler, A., Upton, E., & Newby, J. (2024). Illness Anxiety Disorder: A Review of the Current Research and Future Directions. Current Psychiatry Reports. https://doi.org/10.1007/s11920-024-01507-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.